Up-regulation of SR-BI promotes progression and serves as a prognostic biomarker in clear cell renal cell carcinoma
Open Access
- 22 January 2018
- journal article
- research article
- Published by Springer Nature in BMC Cancer
- Vol. 18 (1) , 1-12
Abstract
Scavenger receptor class B type I (SR-BI) has been reported to be involved in carcinogenesis of several human cancers. However, it is currently unknown whether SR-BI plays a role in clear cell renal cell carcinoma (ccRCC). Here, we aimed to evaluate a tumor promotive mechanism for SR-BI in ccRCC. The expression of SR-BI was evaluated by real-time quantitative reverse transcription polymerase chain reaction (qRT-PCR), Western blot and immunohistochemistry (IHC) in ccRCC tissues and cell lines. Lipid droplets in ccRCC tissues and normal kidney tissues were examined by Oil Red O (ORO) and hematoxylin-eosin (HE) staining. The correlation between SR-BI mRNA levels and clinicopathological features was analyzed by Pearson’s chi-square test or Fisher’s exact test. Kaplan-Meier analysis and Cox model were used to evaluate the difference in progression-free survival (PFS) associated with expression of SR-BI. Inhibition of SR-BI was conducted by using small interfering RNA (siRNA). In vitro assays were performed to assess the impact of SR-BI knockdown on cell biological behaviors. High density lipoprotein (HDL)-cholesterol content in ccRCC cells and extracellular media was also measured after transfection with siRNA. The expression of SR-BI was markedly up-regulated in ccRCC tissues and tumor cell lines. ORO and HE staining revealed huge amounts of lipid droplets accumulation in ccRCC. Clinical analysis showed that over-expression of SR-BI was positively associated with tumor size, grade, distant metastasis and inversely correlated with PFS. Furthermore, SR-BI was proved to be an independent prognostic marker in ccRCC patients. The inhibition of SR-BI attenuated the tumorous behaviors of ccRCC cells, expression of metastasis and AKT pathway related proteins. The content of HDL-cholesterol was reduced in cells while increased in extracellular media after transfection with si-SR-BI. Our results demonstrate that SR-BI functions as an oncogene and promotes progression of ccRCC. SR-BI may serve as a potential prognostic biomarker and therapeutic target for ccRCC.Keywords
Funding Information
- National Natural Science Foundation of China (81272560)
- National Natural Science Foundation of China (81372760)
- National Natural Science Foundation of China (81072095)
- National Natural Science Foundation of China (81672528)
- National High Technology Research and Development Program of China (2012AA021101)
- National Natural Science Foundation of China (31070142)
This publication has 57 references indexed in Scilit:
- Scavenger receptor class B type I regulates cellular cholesterol metabolism and cell signaling associated with breast cancer developmentBreast Cancer Research, 2013
- Expression of CIDE proteins in clear cell renal cell carcinoma and their prognostic significanceMolecular and Cellular Biochemistry, 2013
- Epigenetic expansion of VHL-HIF signal output drives multiorgan metastasis in renal cancerNature Medicine, 2012
- Knockdown of the nucleosome binding protein 1 inhibits the growth and invasion of clear cell renal cell carcinoma cells in vitro and in vivoJournal of Experimental & Clinical Cancer Research, 2012
- A genetically humanized mouse model for hepatitis C virus infectionNature, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Dysregulation of the mevalonate pathway promotes transformationProceedings of the National Academy of Sciences, 2010
- The genetic basis of kidney cancer: a metabolic diseaseNature Reviews Urology, 2010
- Cancer Cell Metabolism: Warburg and BeyondCell, 2008
- Novel approaches in the therapy of metastatic renal cell carcinomaWorld Journal of Urology, 2005